According to Sigma-Aldrich, the strong portfolio of Cell Marque will complement and broaden its diagnostic health reach. Cell Marque's knowledge and experience in the design, validation and ...

Sigma-Aldrich Corporation (SIAL) announced that it has agreed acquire Cell Marque Corporation in order to strengthen its diagnostic health capabilities.

You're currently following this author! Want to unfollow? Unsubscribe via the link in your email. German pharmaceutical and chemical giant Merck announced today that it has agreed to buy Sigma-Aldrich ...

Sigma-Aldrich and Scripps Research Institute California are joining forces to provide “day of publication” access to Scripps-discovered reagents that have utility in drug discovery. The two ...

Add Yahoo as a preferred source to see more of our stories on Google. A branch of drugs and chemicals group Merck is pictured in central German city of Darmstadt March 7, 2012. By Ludwig Burger ...

Merck KGaA may have struggled getting new drug products to market, but its $17 billion buyout of Sigma-Aldrich ($SIAL) will allow it to help others, as well as itself ...

If you're holding any stock in Sigma-Aldrich (NASDAQ: SIAL), you awoke this morning to a wonderful surprise. The original German-based, Merck KGaA is giving you a 37% gift with their purchase of Sigma ...

Merck and Sigma-Aldrich have entered into a definitive agreement under which Merck will acquire Sigma-Aldrich for $17.0 billion (€13.1 billion), establishing one of the leading players in the $130 ...

Jai P. Nagarkatti, chairman, president, and CEO of Sigma-Aldrich died suddenly of an apparent heart attack on Saturday, Nov. 13. The 63-year-old executive had spent his entire career with the company, ...

German drugs and chemicals maker Merck KGaA said Monday it has agreed to acquire U.S.-based Sigma-Aldrich for $17 billion in cash to boost its life science business. The deal, approved by ...

FRANKFURT—German pharmaceutical company Merck KGaA is paying $17 billion to acquire Sigma-Aldrich Corp., a U.S. supplier of laboratory testing materials, as Merck looks to reduce its reliance on ...